Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study

Calvo Martínez, Lourdes

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2975

ISSN: 0732-183X

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2011

Journal title

Journal Of Clinical Oncology

Type of content

Publicación de congreso